The Cancer Letter

Inside information on cancer research and drug development

Vol.
34
No.
1
January 28, 2011Jan 28, 2011
Free
DOWNLOAD THE PDF

XGEVA Improves Metastasis-Free Survival In Castrate-Resistant Prostate Cancer

Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

Genomic Health Presents Meta-Analyses of Oncotype DX

In Phase II Study, NKTR-102 Shows Objective Response

Iniparib Plus Chemo Shows Benefit In Phase II Study

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

Test May Identify Predictors For Recurrence Post-Surgery

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

Clinical Trials Approved By NCI CTEP Last Month

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

Login

Looking for IP Login?